The angiotensin-converting-enzyme system plays an important role in the pathogenesis and progression of endothelial dysfunction, and ACE inhibitors were shown to be useful for reducing the risk of cardiovascular events in clinical and subclinical peripheral artery disease [47]. This evidence concerns the gene ACE and peripheral arterial disease.